IVABRADINE and OFF LABEL USE

Overview

OFF LABEL USE is the #1 most commonly reported adverse reaction for IVABRADINE, manufactured by Amgen Inc. There are 1,295 FDA adverse event reports linking IVABRADINE to OFF LABEL USE. This represents approximately 10.7% of all 12,129 adverse event reports for this drug.

Patients taking IVABRADINE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE is a frequently reported adverse event for IVABRADINE, accounting for a significant proportion of all reports.

Other Side Effects of IVABRADINE

In addition to off label use, the following adverse reactions have been reported for IVABRADINE:

• DYSPNOEA — 460 reports
• HYPOTENSION — 413 reports
• DIZZINESS — 350 reports
• CARDIAC FAILURE — 324 reports
• FATIGUE — 317 reports
• DRUG INTERACTION — 308 reports
• DRUG INEFFECTIVE — 270 reports
• NAUSEA — 253 reports
• BRADYCARDIA — 248 reports
• HEADACHE — 231 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

Does IVABRADINE cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 1,295 FDA reports for IVABRADINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with IVABRADINE?

OFF LABEL USE accounts for approximately 10.7% of all adverse event reports for IVABRADINE, making it one of the most commonly reported side effect.

What should I do if I experience OFF LABEL USE while taking IVABRADINE?

If you experience off label use while taking IVABRADINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages